Skip to main content
. 2019 Oct 10;9:14603. doi: 10.1038/s41598-019-50182-4

Figure 1.

Figure 1

Flow diagram illustrating the study selection process. Between 2017 and 2018, we identified 226 patients, who received hybrid 18F-FET PET/cMRI. According to the eligibility criteria, a total of 42 patients with glioma recurrence in question were included into our retrospective study.